CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 770 of 1
Non-Antibody Products
Page 770 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| MK-8617 | A HIF-PH1, -2, and -3 inhibitor (IC50s = 1, 1, and 14 nM, respectively); s… | 50 mg | 33790-50 | More Info |
| MK-8669 | A rapamycin analog that selectively inhibits mTOR (IC50 = 0.2 nM); binds F… | 1 mg | 10543-1 | More Info |
| MK-8669 | A rapamycin analog that selectively inhibits mTOR (IC50 = 0.2 nM); binds F… | 10 mg | 10543-10 | More Info |
| MK-8669 | A rapamycin analog that selectively inhibits mTOR (IC50 = 0.2 nM); binds F… | 5 mg | 10543-5 | More Info |
| MK-8722 | An AMPK activator; activates Ampk and increases phosphorylated Acc1 levels… | 1 mg | 37578-1 | More Info |
| MK-8722 | An AMPK activator; activates Ampk and increases phosphorylated Acc1 levels… | 10 mg | 37578-10 | More Info |
| MK-8722 | An AMPK activator; activates Ampk and increases phosphorylated Acc1 levels… | 25 mg | 37578-25 | More Info |
| MK-8722 | An AMPK activator; activates Ampk and increases phosphorylated Acc1 levels… | 5 mg | 37578-5 | More Info |
| MK-8745 | An Aurora A kinase inhibitor (IC50 = 0.6 nM); selective for Aurora A over… | 10 mg | 26190-10 | More Info |
| MK-8745 | An Aurora A kinase inhibitor (IC50 = 0.6 nM); selective for Aurora A over… | 25 mg | 26190-25 | More Info |
| MK-8745 | An Aurora A kinase inhibitor (IC50 = 0.6 nM); selective for Aurora A over… | 5 mg | 26190-5 | More Info |
| MK-8745 | An Aurora A kinase inhibitor (IC50 = 0.6 nM); selective for Aurora A over… | 50 mg | 26190-50 | More Info |
| MK-886 | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 1 mg | 21753-1 | More Info |
| MK-886 | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 10 mg | 21753-10 | More Info |
| MK-886 | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 25 mg | 21753-25 | More Info |
| MK-886 | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 5 mg | 21753-5 | More Info |
| MK2a Inhibitor | A substrate-selective p38α MAPK inhibitor; selectively inhibits p38&… | 1 mg | 17325-1 | More Info |
| MK2a Inhibitor | A substrate-selective p38α MAPK inhibitor; selectively inhibits p38&… | 10 mg | 17325-10 | More Info |
| MK2a Inhibitor | A substrate-selective p38α MAPK inhibitor; selectively inhibits p38&… | 5 mg | 17325-5 | More Info |
| MK2a Inhibitor | A substrate-selective p38α MAPK inhibitor; selectively inhibits p38&… | 50 mg | 17325-50 | More Info |
| MKC-3946 | An inhibitor of IRE1α; inhibits ER stress induced XBP1 splicing and… | 1 mg | 19152-1 | More Info |
| MKC-3946 | An inhibitor of IRE1α; inhibits ER stress induced XBP1 splicing and… | 10 mg | 19152-10 | More Info |
| MKC-3946 | An inhibitor of IRE1α; inhibits ER stress induced XBP1 splicing and… | 25 mg | 19152-25 | More Info |
| MKC-3946 | An inhibitor of IRE1α; inhibits ER stress induced XBP1 splicing and… | 5 mg | 19152-5 | More Info |
| MKC8866 | An inhibitor of IRE1α RNase activity (IC50 = 0.29 µM); inhibit… | 10 mg | 37332-10 | More Info |
| MKC8866 | An inhibitor of IRE1α RNase activity (IC50 = 0.29 µM); inhibit… | 25 mg | 37332-25 | More Info |
| MKC8866 | An inhibitor of IRE1α RNase activity (IC50 = 0.29 µM); inhibit… | 5 mg | 37332-5 | More Info |
| MKC8866 | An inhibitor of IRE1α RNase activity (IC50 = 0.29 µM); inhibit… | 50 mg | 37332-50 | More Info |
| MK-212 (hydrochloride) | A 5-HT2C receptor agonist (EC50 = 0.028 µM in a calcium mobilization… | 10 mg | 36089-10 | More Info |
| MK-212 (hydrochloride) | A 5-HT2C receptor agonist (EC50 = 0.028 µM in a calcium mobilization… | 100 mg | 36089-100 | More Info |
| MK-212 (hydrochloride) | A 5-HT2C receptor agonist (EC50 = 0.028 µM in a calcium mobilization… | 5 mg | 36089-5 | More Info |
| MK-212 (hydrochloride) | A 5-HT2C receptor agonist (EC50 = 0.028 µM in a calcium mobilization… | 50 mg | 36089-50 | More Info |
| MK-2206 (hydrochloride) | An orally active, allosteric Akt inhibitor (IC50s = 5, 12, and 65 nM for A… | 1 mg | 11593-1 | More Info |
| MK-2206 (hydrochloride) | An orally active, allosteric Akt inhibitor (IC50s = 5, 12, and 65 nM for A… | 10 mg | 11593-10 | More Info |
| MK-2206 (hydrochloride) | An orally active, allosteric Akt inhibitor (IC50s = 5, 12, and 65 nM for A… | 25 mg | 11593-25 | More Info |
| MK-2206 (hydrochloride) | An orally active, allosteric Akt inhibitor (IC50s = 5, 12, and 65 nM for A… | 5 mg | 11593-5 | More Info |
| (+)-MK-801 (hydrogen maleate) | Potent, selective and non-competitive NMDA receptor antagonist (Ki = 30.5… | 10 mg | 10009019-10 | More Info |
| (+)-MK-801 (hydrogen maleate) | Potent, selective and non-competitive NMDA receptor antagonist (Ki = 30.5… | 50 mg | 10009019-50 | More Info |
| MK2 Inhibitor III | A potent, cell-permeable inhibitor of MK2 (IC50 = 8.5 nM); less potently b… | 1 mg | 15943-1 | More Info |
| MK2 Inhibitor III | A potent, cell-permeable inhibitor of MK2 (IC50 = 8.5 nM); less potently b… | 5 mg | 15943-5 | More Info |
| MK2 Inhibitor III | A potent, cell-permeable inhibitor of MK2 (IC50 = 8.5 nM); less potently b… | 500 µg | 15943-500 | More Info |
| MK2 Inhibitor IV | A highly selective, non-ATP competitive inhibitor of p38 / mitogen-activat… | 10 mg | 14399-10 | More Info |
| MK2 Inhibitor IV | A highly selective, non-ATP competitive inhibitor of p38 / mitogen-activat… | 25 mg | 14399-25 | More Info |
| MK2 Inhibitor IV | A highly selective, non-ATP competitive inhibitor of p38 / mitogen-activat… | 5 mg | 14399-5 | More Info |
| MK-571 (sodium salt) | A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… | 1 mg | 70720-1 | More Info |
| MK-571 (sodium salt) | A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… | 10 mg | 70720-10 | More Info |
| MK-571 (sodium salt) | A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… | 5 mg | 70720-5 | More Info |
| MK-571 (sodium salt) | A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… | 50 mg | 70720-50 | More Info |
| MK-886 (sodium salt) | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 1 mg | 10133-1 | More Info |
| MK-886 (sodium salt) | A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… | 10 mg | 10133-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile